Clinical Trial Update: A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial assessing risperidone for behavioral disorders in learning-disabled children following psychological thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behavioral Disorders in Children
• Learning Disabilities

Drugs mentioned

• Risperdal (risperidone)

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: Learning Disorders, Child Behavior Disorders | Phase 3 | Status: COMPLETED